CEP
IRWD icon

Chicago Equity Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Chicago Equity Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2.65M Sell
262,577
-154,830
-37% -$1.82M 0.27% 95
2019
Q4 		$5.56M Buy
417,407
+33,252
+9% +$367K 0.32% 68
2019
Q3 		$3.3M Sell
384,155
-1,445
-0.4% -$14K 0.16% 190
2019
Q2 		$4.22M Sell
385,600
-78,191
-17% -$876K 0.19% 141
2019
Q1 		$5.26M Buy
463,791
+127,190
+38% +$1.42M 0.2% 130
2018
Q4 		$2.92M Sell
336,601
-11,050
-3% -$127K 0.12% 248
2018
Q3 		$5.38M Buy
347,651
+55,987
+19% +$885K 0.16% 174
2018
Q2 		$4.67M Buy
291,664
+28,088
+11% +$416K 0.14% 205
2018
Q1 		$3.41M Buy
263,576
+8,442
+3% +$105K 0.11% 269
2017
Q4 		$3.2M Buy
255,134
+114,081
+81% +$1.49M 0.1% 269
2017
Q3 		$1.86M Sell
141,053
-39,038
-22% -$537K 0.06% 385
2017
Q2 		$2.85M Buy
180,091
+33,659
+23% +$489K 0.08% 303
2017
Q1 		$2.09M Sell
146,432
-17,265
-11% -$236K 0.06% 315
2016
Q4 		$2.1M Buy
163,697
+60,643
+59% +$766K 0.06% 324
2016
Q3 		$1.37M Buy
+103,054
New +$1.2M 0.04% 374

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Chicago Equity Partners's IRWD Position: Q1 2020 in Review

Chicago Equity Partners reduced its Ironwood Pharmaceuticals (IRWD) stake by 37% in Q1 2020, selling an estimated $1.82M and leaving 262,577 shares worth $2.65M. The position accounts for 0.27% of the portfolio, ranked #95.

Chicago Equity Partners first reported a position in IRWD in Q3 2016 and has held it in 15 quarters since. The position peaked at $5.56M in Q4 2019. 193 funds tracked by Wall St. Rank hold IRWD as of Q1 2020.

  • Chicago Equity Partners held 262,577 shares of Ironwood Pharmaceuticals worth $2.65M as of Q1 2020.
  • Chicago Equity Partners sold 154,830 Ironwood Pharmaceuticals shares in Q1 2020, an estimated $1.82M.
  • Ironwood Pharmaceuticals made up 0.27% of Chicago Equity Partners's portfolio in Q1 2020, its #95 holding.
  • Chicago Equity Partners first reported a position in Ironwood Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
  • Chicago Equity Partners's Ironwood Pharmaceuticals position peaked at $5.56M in Q4 2019.
  • 193 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.